Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.

Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, Donnell D, Celum C, Kapiga S, Delany S, Bukusi EA.

PLoS Med. 2012;9(6):e1001251. doi: 10.1371/journal.pmed.1001251. Epub 2012 Jun 26.

2.

Patterns and predictors of adherence to diaphragm use in a phase III trial in sub-Saharan Africa: a trajectory analysis.

van der Straten A, Shiboski S, Montgomery ET, Moore J, De Bruyn G, Ramjee G, Chidanyika A, Kacanek D, Padian N; MIRA Team.

J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):419-26. doi: 10.1097/QAI.0b013e3181958511.

PMID:
19214115
3.

The use of the diaphragm instead of condoms in a phase III diaphragm trial.

van der Straten A, Cheng H, Moore J, Kacanek D, Blanchard K, De Bruyn G, Ramjee G, Chipato T, Montgomery ET, Padian N; MIRA Team.

AIDS Behav. 2009 Jun;13(3):564-72. doi: 10.1007/s10461-008-9504-z. Epub 2008 Dec 16.

PMID:
19085099
4.

Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment.

Rebbapragada A, Howe K, Wachihi C, Pettengell C, Sunderji S, Huibner S, Ball TB, Plummer FA, Jaoko W, Kaul R.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):520-2. doi: 10.1097/QAI.0b013e318189a7ca.

PMID:
18989228
5.

Probiotics: potential to prevent HIV and sexually transmitted infections in women.

Bolton M, van der Straten A, Cohen CR.

Sex Transm Dis. 2008 Mar;35(3):214-25. doi: 10.1097/OLQ.0b013e31815b017a. Review.

PMID:
18490864
6.

Comparative study of intravaginal metronidazole and triple-sulfa therapy for bacterial vaginosis.

Sobel JD, Chaim W, Thomason J, Livengood C, Sweet R, McGregor JA, Eschenbach D, Hillier S, Galask R, Faro S, Shangle E, Baker D.

Infect Dis Obstet Gynecol. 1996;4(2):66-70.

7.

A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe.

van der Straten A, Napierala S, Cheng H, Mauck C, Depineres T, Dhlakama P, Thompson M, Chipato T, Hammond N, Padian N.

Contraception. 2007 Nov;76(5):389-99. Epub 2007 Sep 21.

PMID:
17963865
8.

Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.

Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, van der Laan M, Jewell N, McIntyre J; MIRA Team.

Lancet. 2007 Jul 21;370(9583):251-61.

9.

Bacterial flora of the female genital tract: function and immune regulation.

Witkin SS, Linhares IM, Giraldo P.

Best Pract Res Clin Obstet Gynaecol. 2007 Jun;21(3):347-54. Epub 2007 Jan 9. Review.

PMID:
17215167
10.
11.

Bacterial vaginosis: risk factors among Kenyan women and their male partners.

Bukusi EA, Cohen CR, Meier AS, Waiyaki PG, Nguti R, Njeri JN, Holmes KK.

Sex Transm Dis. 2006 Jun;33(6):361-7.

PMID:
16547451
12.

Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial.

Sanchez S, Garcia PJ, Thomas KK, Catlin M, Holmes KK.

Am J Obstet Gynecol. 2004 Dec;191(6):1898-906.

PMID:
15592270
13.

Efficacy and tolerability of a new chlorhexidine-based vaginal gel in vaginal infections.

Molteni B, D'Antuono A, Bandini P, Sintini G, Barcellona E, Agnello A, Milani M.

Curr Med Res Opin. 2004 Jun;20(6):849-53.

PMID:
15200742
14.

Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis.

Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL.

Clin Infect Dis. 2003 Aug 1;37(3):319-25. Epub 2003 Jul 15.

PMID:
12884154
16.

Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services.

Sánchez J, Campos PE, Courtois B, Gutierrez L, Carrillo C, Alarcon J, Gotuzzo E, Hughes J, Watts D, Hillier SL, Buchanan K, Holmes KK.

Sex Transm Dis. 2003 Apr;30(4):273-9.

PMID:
12671544
17.

Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis.

Sobel J, Peipert JF, McGregor JA, Livengood C, Martin M, Robbins J, Wajszczuk CP.

Infect Dis Obstet Gynecol. 2001;9(1):9-15.

18.

Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites.

van De Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, Kumwenda N, Chirenje Z, Joshi S, Taha T, Padian N, Bollinger R, Nelson K.

J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):21-7.

PMID:
11176265
19.

Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis.

Hashemi FB, Ghassemi M, Faro S, Aroutcheva A, Spear GT.

J Infect Dis. 2000 May;181(5):1574-80. Epub 2000 May 15.

PMID:
10823756
20.

Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation.

Gupta K, Hillier SL, Hooton TM, Roberts PL, Stamm WE.

J Infect Dis. 2000 Feb;181(2):595-601.

PMID:
10669343

Supplemental Content

Support Center